Indoleamine 2,3-dioxygenase (IDO) is an intracellular heme-containing enzyme that is activated by proinflammatory cytokines, including interferon-c (IFNc), and metabolizes tryptophan along the kynurenine pathway. Activation of murine macrophages induces not only IDO but also nitric oxide synthase (iNOS), and the ensuing production of nitric oxide (NO) inhibits IDO. To determine the sensitivity of primary cultures of murine microglia to NO, microglia were stimulated with recombinant murine IFNc (1 ng/ml) and lipopolysaccharide (LPS) (10 ng/ml). This combination of IFNc + LPS synergized to produce maximal amounts of nitrite as early as 16 h. Steady-state mRNAs for both iNOS and IDO were significantly increased by IFNc + LPS at 4 h post-treatment, followed by an increase in IDO enzymatic activity at 24 h. Murine microglia (>95% CD11b + ) were pretreated with the iNOS inhibitor, L-NIL hydrochloride, at a dose (30 lM) that completely abrogated production of nitrite. L-NIL had no effect on IDO mRNA at 4 h or IDO enzymatic activity at 24 h following stimulation with IFNc + LPS. These data establish that IDO regulation in murine microglia is not restrained by NO, thereby permitting the accumulation of kynurenine and its downstream metabolites in the central nervous system.
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Introduction
Indoleamine 2,3-dioxygenase (IDO) is an intracellular monomeric heme-containing enzyme that catalyzes the first and ratelimiting step that degrades the essential amino acid tryptophan in extrahepatic tissues (Rafice et al., 2009) . IDO is induced during immune responses in many types of cells, including those in the central nervous system (CNS) (Connor et al., 2008; Fujigaki et al., 2006; Guillemin et al., 2005; Jung et al., 2007) . Activation of IDO causes degradation of the essential amino acid tryptophan to kynurenine and other metabolites of the kynurenine (Taylor and Feng, 1991) . Besides its importance for the development of immunotolerance, activation of IDO is implicated in the pathophysiology of psychiatric disorders (Dantzer et al., 2008; Perez-De La Cruz et al., 2007; Widner et al., 2002) . IDO activation is regulated by many factors, an important one of which is nitric oxide (NO) (Thomas and Stocker, 1999) . The inducible form of nitric oxide synthase iNOS is a calcium-independent enzyme that upon stimulation produces large quantities of NO (MacMicking et al., 1997) . Activation of murine, but not human macrophages increases the expression and activity of iNOS (Sethi and Dikshit, 2000) . An important interaction between iNOS and IDO is that the product(s) of one pathway regulate(s) the enzyme of the other pathway (Oh et al., 2004; Oxenkrug, 2007; Samelson-Jones and Yeh, 2006) . As a result of this crosstalk, NO is well known to inhibit IDO activity in many types of cells (Fujigaki et al., 2002; Hucke et al., 2004; Samelson-Jones and Yeh, 2006; Thomas et al., 1994) .
Microglia act as resident mononuclear myeloid cells in the brain (Soulet and Rivest, 2008) , and these resident CNS microglia are composed of heterogeneous populations (Schmid et al., 2009) . Microglia are activated in most pathological conditions of the CNS and play an important role in sensing and propagating inflammatory signals in response to activation of the peripheral innate immune system (Hanisch and Kettenmann, 2007) . Activated microglia are a major source of IDO activity in the brain (Kwidzinski et al., 2005) . Along with the production of kynurenines, activated murine microglia also produce large amounts of NO via enhanced expression of iNOS (Cheret et al., 2008; Mir et al., 2008 
